MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    A Case series of Hemichorea Hemiballism Associated with Non-ketotic Hyperglycemia and Unique Imaging findings

    RP. Vasireddy, M. Thandampallayam, Z. Guduru (Lexington, USA)

    Objective: To avoid missed diagnosis of non-ketotic hyperglycemic hemichorea hemiballismus by discussing the phenomenology, radiological findings and therapy through this case series. Background: Hemichorea–hemiballismus associated…
  • 2022 International Congress

    The barriers and facilitators to satisfaction with botulinum neurotoxin treatment in people with cervical dystonia: a systematic review.

    M. Boyce, A. Mccambridge, L. Bradnam, C. Canning, A. Verhagen (Ultimo, Australia)

    Objective: This systematic review aimed to determine the barriers to satisfaction and facilitators that could improve satisfaction with BoNT therapy for people with CD. Background:…
  • 2022 International Congress

    Digital Sway Measures for Spinocerebellar Ataxia

    V. Shah, J. Mcnames, H. Casey, K. Floyd, R. Rodriguez-Labrada, J. Schmahmann, L. Rosenthal, S. Perlman, M. El Gohary, K. Sowalsky,, M. Mancini, L. Velázquez-Pérez, F. Horak, C. Gomez (Portland, USA)

    Objective: The objective of the study was to investigate which postural sway condition and which measures are most sensitive to prodromal and manifest spinocerebellar ataxia…
  • 2022 International Congress

    Association of glucocerebrosidase genotype and disease progression in early Parkinson’s disease over the course of 80 weeks

    H. Frequin, B. Ferwerda, C. Verschuur, S. Suwijn, J. Dijk, R. de Bie (Amsterdam, Netherlands)

    Objective: *Background and objectiveWe conducted post-hoc analyses with data of the Levodopa in EArly Parkinson’s disease (LEAP) study to compare the rate ofdisease progression in…
  • 2022 International Congress

    Cognitive behavioral therapy for anxiety in Parkinson’s disease induces functional brain changes

    G. Carey, R. Lopes, A. Moonen, A. Mulders, J. de Jong, G. Kuchcinski, L. Defebvre, M. Kuijf, K. Dujardin, A. Leentjens (Lille, France)

    Objective: To identify changes in functional connectivity in the brain after cognitive behavioral therapy (CBT) for anxiety in patients with Parkinson's disease (PD). Background: CBT…
  • 2022 International Congress

    Highlighting the dystonic phenotype related to GNAO1

    T. Wirth, G. Garone, M. Kurian, A. Piton, F. Milan, A. Telegrafi, N. Drouot, G. Rudolf, J. Chelly, W. Marks, L. Burglen, D. Demailly, P. Coubes, M. Castro-Jimenez, S. Joriot, J. Ghoumid, J. Belin, J-M. Faucheux, L. Blumkin, M. Hull, M. Parnes, C. Ravelli, A. Nemeth, M. Smith, A. Barnicoat, C. Ewenczyk, A. Méneret, E. Roze, B. Keren, C. Mignot, C. Beroud, F. Acosta, C. Nowak, W. Wilson, D. Steel, A. Capuano, M. Vidailhet, J-P. Lin, C. Tranchant, L. Cif, D. Doummar, M. Anheim (Strasbourg, France)

    Objective: To characterize the clinical and genetic features of patients with mild GNAO1-related phenotype with prominent movement disorders. Background: Most reported patients carrying GNAO1 mutations…
  • 2022 International Congress

    De novo mutation in TMEM151A and Paroxysmal Kinesigenic Dyskinesia

    T. Wirth, A. Méneret, N. Drouot, G. Rudolf, O. Lagha-Boukbiza, J. Chelly, C. Tranchant, A. Piton, E. Roze, M. Anheim (Strasbourg, France)

    Objective: To confirm the association between TMEM151A mutation and paroxysmal kinesigenic dyskinesia. Background: Heterozygous mutations in TMEM151A, encoding a protein of undetermined function, have been…
  • 2022 International Congress

    Effect of levodopa-carbidopa intestinal gel on lower urinary tract symptoms in Parkinson’s disease: an Urodynamic study

    D. Rinaldi, O. Voglino, A. Tubaro, FE. Pontieri (rome, Italy)

    Objective: Here we report urodynamic results before and six months after LCIG treatment in PD patients suffering from LUTS. Background: Dopaminergic transmission plays a key…
  • 2022 International Congress

    Dysphagia and its relationship to medication intake in Parkinson’s disease

    B. Labeit, E. Berkovich, I. Claus, M. Roderigo, AL. Schwake, D. Izgelov, D. Mimrod, S. Ahring, S. Oeleberg, P. Muhle, V. Zentsch, F. Wenninger, S. Suntrup-Krueger, R. Dziewas, T. Warnecke (Muenster, Germany)

    Objective: This study attempted to obtain a comprehensive picture of medication intake dysphagia in Parkinson’s disease (PD). Specific investigations included 1) An objective, graduated and…
  • 2022 International Congress

    Factors related to the antidepressant effect of safinamide in Parkinson’s disease. A post-hoc analysis of SADNESS-PD study

    E. Peña, C. Borrué, M. Mata, JC. Martínez-Castrillo, A. Alonso-Canovas, JL. Chico, L. López-Manzanares, M. Llanero, J. Herreros-Rodríguez, A. Esquivel, T. Maycas-Cepeda, C. Ruíz-Huete (Madrid, Spain)

    Objective: To assess the role of different factors in the antidepressant effect of safinamide in Parkinson’s disease (PD) Background: SADNESS-PD was a real-life, multicenter, retrospective…
  • « Previous Page
  • 1
  • …
  • 513
  • 514
  • 515
  • 516
  • 517
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley